Pioglitazone - PDFSEARCH.IO - Document Search Engine

Pioglitazone
Results: 289

#	Item
101	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ACTOPLUS MET safely and effectively. See full prescribing information for ACT OPLUS MET. ACTOPLUS MET (pioglitazone Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-08-19 16:22:00 Biguanides Guanidines Organic chemistry Pyridines Eli Lilly and Company Pioglitazone Metformin Politor Anti-diabetic medication Medicine Chemistry Thiazolidinediones
102	Joslin Diabetes Center & Joslin Clinic Clinical Guideline for Pharmacological Management of Adults with Type 2 Diabetes[removed]The objectives of the Joslin Diabetes Center & Joslin Clinic Clinical Guideline for Pharm Add to Reading List Source URL: www.joslin.org Language: English - Date: 2014-11-03 00:05:29 Gastroenterology Eli Lilly and Company Thiazolidinediones Anti-diabetic drugs Guanidines Anti-diabetic medication Metformin Exenatide Pioglitazone Endocrine system Diabetes Medicine
103	Rosiglitazone FDA Advisory Committee July 2010 Diana Zuckerman, PhD President National Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Research Pharmacology Design of experiments Epidemiology Rosiglitazone Pioglitazone Food and Drug Administration Clinical trial Pyridines Thiazolidinediones Chemistry
104	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Source URL: www.fda.gov Language: English Pioglitazone Rosiglitazone Science Methodology Systematic review Meta-analysis Sociology Thiazolidinediones Pyridines Eli Lilly and Company
105	Advisory Committee Meeting Avandia® (rosiglitazone maleate) July 13-14, 2010 Mary H. Parks, M.D. Division of Metabolism and Endocrinology Products Add to Reading List Source URL: www.fda.gov Language: English Rosiglitazone Eli Lilly and Company Pioglitazone Anti-diabetic drugs Science Anti-diabetic medication Methodology Meta-analysis Sociology Pyridines Thiazolidinediones GlaxoSmithKline
106	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Source URL: www.fda.gov Language: English GlaxoSmithKline Rosiglitazone Eli Lilly and Company Pioglitazone Anti-diabetic drugs Pharmaceutical sciences Anti-diabetic medication Food and Drug Administration Thiazolidinediones Pyridines Chemistry
107	PDF Document Add to Reading List Source URL: www.fda.gov Language: English Diabetes Pyridines Endocrine system Anti-diabetic drugs GlaxoSmithKline Rosiglitazone Anti-diabetic medication Pioglitazone Metformin Thiazolidinediones Chemistry Organic chemistry
108	Pioglitazone and Rosiglitazone Cardiovascular Safety Meta-Analyses Bradley McEvoy, MS, DrPH Statistical Reviewer Division of Biometrics VII Office of Biostatistics, CDER, FDA Add to Reading List Source URL: www.fda.gov Language: English Pioglitazone Rosiglitazone Science Methodology Systematic review Meta-analysis Sociology Thiazolidinediones Pyridines Eli Lilly and Company
109	PDF Document Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:51:17 Diabetes Endocrine system Chemistry Anti-diabetic drugs Gastroenterology Politor Metformin Pioglitazone Anti-diabetic medication Thiazolidinediones Biguanides Guanidines
110	Regulatory Perspectives on Inhalation Drug Delivery: U.S. View Add to Reading List Source URL: www.fda.gov Language: English Organic chemistry GlaxoSmithKline Rosiglitazone Pioglitazone Metformin Pyridines Thiazolidinediones Chemistry

UPDATE